Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1

Acta Neuropathologica

Volumn 131, Issue 4, 2016, Pages 539-548

  Brahic, Michel ^a   Bousset, Luc ^b   Bieri, Gregor ^a   Melki, Ronald ^b   Gitler, Aaron D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CNRS   (France)

Author keywords

Axonal transport; A 42; HTTExon1; Secretion; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ARMADILLO DOMAIN PROTEIN; CHOLERA TOXIN; CYTOSKELETON PROTEIN; GLUTATHIONE PEROXIDASE; HTT PROTEIN, HUMAN; HUNTINGTIN; MULTIPROTEIN COMPLEX; PEPTIDE FRAGMENT; POLYGLUTAMIC ACID; PRION; SACCHAROMYCES CEREVISIAE PROTEIN; SARM1 PROTEIN, MOUSE; SUP35 PROTEIN, S CEREVISIAE; TRANSLATION TERMINATION FACTOR; URE2 PROTEIN, S CEREVISIAE;

ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; COMPARATIVE STUDY; EMBRYO; FIBER; MICROFLUIDICS; MOUSE; NERVE CELL CULTURE; NERVE FIBER DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN SECRETION; PROTEIN TRANSPORT; SECRETORY PATHWAY; WESTERN BLOTTING; ANIMAL; BRAIN; C57BL MOUSE; GENETICS; HUMAN; KNOCKOUT MOUSE; LAB ON A CHIP; MAMMALIAN EMBRYO; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PRION;

ALPHA-SYNUCLEIN; AMYLOID BETA-PEPTIDES; ANIMALS; ARMADILLO DOMAIN PROTEINS; AXONAL TRANSPORT; BRAIN; CHOLERA TOXIN; CYTOSKELETAL PROTEINS; EMBRYO, MAMMALIAN; GLUTATHIONE PEROXIDASE; HUMANS; HUNTINGTIN PROTEIN; LAB-ON-A-CHIP DEVICES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; NEURONS; PEPTIDE FRAGMENTS; PEPTIDE TERMINATION FACTORS; POLYGLUTAMIC ACID; PRIONS; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84961135800     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-016-1538-0     Document Type: Article

References (55)

1. Aguzzi A, Gitler AD (2013) A template for new drugs against Alzheimer’s disease. Cell 154:1182–1184. doi:10.1016/j.cell.2013.08.049
2. Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42:360–367. doi:10.1016/j.nbd.2011.01.029
3. Angelucci A, Clasca F, Sur M (1996) Anterograde axonal tracing with the subunit B of cholera toxin: a highly sensitive immunohistochemical protocol for revealing fine axonal morphology in adult and neonatal brains. J Neurosci Methods 65:101–112
4. Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, Madiona K, Olieric V, Bockmann A, Meier BH et al (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575. doi:10.1038/ncomms3575
5. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):Iii/1–Iii/5
6. Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna, Austria: 1996) 110:517–536. doi:10.1007/s00702-002-0808-2
7. Chutna O, Goncalves S, Villar-Pique A, Guerreiro P, Marijanovic Z, Mendes T, Ramalho J, Emmanouilidou E, Ventura S, Klucken J et al (2014) The small GTPase Rab11 co-localizes with alpha-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity. Hum Mol Genet 23:6732–6745. doi:10.1093/hmg/ddu391
8. Cicchetti F, Lacroix S, Cisbani G, Vallieres N, Saint-Pierre M, St-Amour I, Tolouei R, Skepper JN, Hauser RA, Mantovani D et al (2014) Mutant huntingtin is present in neuronal grafts in Huntington disease patients. Ann Neurol 76:31–42. doi:10.1002/ana.24174
9. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909–913. doi:10.1038/ncb1901
10. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 123:1191–1201. doi:10.1242/jcs.051672
11. Dalod M (2007) Studies of SARM1 uncover similarities between immune and neuronal responses to danger. Sci STKE Signal Transduct Knowl Environ 2007:pe73. doi:10.1126/stke.4172007pe73
12. Danzer KM, Krebs SK, Wolff M, Birk G, Hengerer B (2009) Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 111:192–203. doi:10.1111/j.1471-4159.2009.06324.x
13. de Calignon A, Polydoro M, Suarez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA et al (2012) Propagation of tau pathology in a model of early Alzheimer’s disease. Neuron 73:685–697. doi:10.1016/j.neuron.2011.11.033
14. Decker H, Lo KY, Unger SM, Ferreira ST, Silverman MA (2010) Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J Neurosci 30:9166–9171. doi:10.1523/jneurosci.1074-10.2010
15. Eisele YS, Obermuller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M (2010) Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science (New York, NY) 330:980–982. doi:10.1126/science.1194516
16. Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30:6838–6851. doi:10.1523/jneurosci.5699-09.2010
17. Ericson H, Blomqvist A (1988) Tracing of neuronal connections with cholera toxin subunit B: light and electron microscopic immunohistochemistry using monoclonal antibodies. J Neurosci Methods 24:225–235
18. Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M (2012) Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol 72:517–524. doi:10.1002/ana.23747
19. Ghee M, Melki R, Michot N, Mallet J (2005) PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly. FEBS J 272:4023–4033. doi:10.1111/j.1742-4658.2005.04776.x
20. Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer’s disease. Neurobiol Aging 26:1235–1244. doi:10.1016/j.neurobiolaging.2005.05.022
21. Hansen C, Angot E, Bergstrom AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K et al (2011) alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Investig 121:715–725. doi:10.1172/jci43366
22. Hiruma H, Katakura T, Takahashi S, Ichikawa T, Kawakami T (2003) Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J Neurosci 23:8967–8977
23. Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI (2012) Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem 287:19440–19451. doi:10.1074/jbc.M112.346072
24. Kordower JH, Brundin P (2009) Propagation of host disease to grafted neurons: accumulating evidence. Exp Neurol 220:224–225. doi:10.1016/j.expneurol.2009.09.016
25. Krzewska J, Melki R (2006) Molecular chaperones and the assembly of the prion Sup35p, an in vitro study. EMBO J 25:822–833. doi:10.1038/sj.emboj.7600985
26. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A et al (2008) Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat Med 14:501–503. doi:10.1038/nm1746
27. Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R (2013) Molecular structure of beta-amyloid fibrils in Alzheimer’s disease brain tissue. Cell 154:1257–1268. doi:10.1016/j.cell.2013.08.035
28. Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science (New York, NY) 338:949–953. doi:10.1126/science.1227157
29. Luk KC, Kehm VM, Zhang B, O’Brien P, Trojanowski JQ, Lee VM (2012) Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209:975–986. doi:10.1084/jem.20112457
30. Luk KC, Song C, O’Brien P, Stieber A, Branch JR, Brunden KR, Trojanowski JQ, Lee VM (2009) Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 106:20051–20056. doi:10.1073/pnas.0908005106
31. Lyon MF, Ogunkolade BW, Brown MC, Atherton DJ, Perry VH (1993) A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc Natl Acad Sci USA 90:9717–9720
32. Monsellier E, Redeker V, Ruiz-Arlandis G, Bousset L, Melki R (2015) Molecular interaction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1 modulates aggregation. J Biol Chem 290:2560–2576. doi:10.1074/jbc.M114.603332
33. Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M (2010) Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem 285:34885–34898. doi:10.1074/jbc.M110.148460
34. Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, Sheehan AE, Avery MA, Hackett R, Logan MA et al (2012) dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science (New York, NY) 337:481–484. doi:10.1126/science.1223899
35. Pecho-Vrieseling E, Rieker C, Fuchs S, Bleckmann D, Esposito MS, Botta P, Goldstein C, Bernhard M, Galimberti I, Muller M et al (2014) Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons. Nat Neurosci 17:1064–1072. doi:10.1038/nn.3761
36. Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, Baekelandt V (2015) alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. doi:10.1038/nature14547
37. Pieri L, Madiona K, Bousset L, Melki R (2012) Fibrillar alpha-synuclein and huntingtin exon 1 assemblies are toxic to the cells. Biophys J 102:2894–2905. doi:10.1016/j.bpj.2012.04.050
38. Pigino G, Morfini G, Atagi Y, Deshpande A, Yu C, Jungbauer L, LaDu M, Busciglio J, Brady S (2009) Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci USA 106:5907–5912. doi:10.1073/pnas.0901229106
39. Prusiner SB (1984) Some speculations about prions, amyloid, and Alzheimer’s disease. N Engl J Med 310:661–663. doi:10.1056/nejm198403083101021
40. Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11:219–225. doi:10.1038/ncb1830
41. Roy S (2014) Seeing the unseen: the hidden world of slow axonal transport. Neuroscientist 20:71–81. doi:10.1177/1073858413498306
42. Roy S, Winton MJ, Black MM, Trojanowski JQ, Lee VM (2007) Rapid and intermittent cotransport of slow component-b proteins. J Neurosci 27:3131–3138. doi:10.1523/jneurosci.4999-06.2007
43. Ruiz-Arlandis G, Pieri L, Bousset L, Melki R (2015) Binding, internalization and fate of Huntingtin Exon1 fibrillar assemblies in mitotic and nonmitotic neuroblastoma cells. Neuropathol Appl Neurobiol. doi:10.1111/nan.12258
44. Scott DA, Das U, Tang Y, Roy S (2011) Mechanistic logic underlying the axonal transport of cytosolic proteins. Neuron 70:441–454. doi:10.1016/j.neuron.2011.03.022
45. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161:1869–1879
46. Tang Y, Scott DA, Das U, Edland SD, Radomski K, Koo EH, Roy S (2012) Early and selective impairments in axonal transport kinetics of synaptic cargoes induced by soluble amyloid beta-protein oligomers. Traffic (Copenhagen, Denmark) 13:681–693. doi:10.1111/j.1600-0854.2012.01340.x
47. Taylor AM, Blurton-Jones M, Rhee SW, Cribbs DH, Cotman CW, Jeon NL (2005) A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2:599–605. doi:10.1038/nmeth777
48. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800
49. Thual C, Komar AA, Bousset L, Fernandez-Bellot E, Cullin C, Melki R (1999) Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J Biol Chem 274:13666–13674
50. Tsunemi T, Hamada K, Krainc D (2014) ATP13A2/PARK9 regulates secretion of exosomes and alpha-synuclein. J Neurosci 34:15281–15287. doi:10.1523/jneurosci.1629-14.2014
51. Ulusoy A, Musgrove RE, Rusconi R, Klinkenberg M, Helwig M, Schneider A, Di Monte DA (2015) Neuron-to-neuron alpha-synuclein propagation in vivo is independent of neuronal injury. Acta Neuropathol Commun 3:13. doi:10.1186/s40478-015-0198-y
52. Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57–71. doi:10.1016/j.neuron.2011.08.033
53. Walsh DM, Thulin E, Minogue AM, Gustavsson N, Pang E, Teplow DB, Linse S (2009) A facile method for expression and purification of the Alzheimer’s disease-associated amyloid beta-peptide. FEBS J 276:1266–1281. doi:10.1111/j.1742-4658.2008.06862.x
54. Wang JT, Medress ZA, Barres BA (2012) Axon degeneration: molecular mechanisms of a self-destruction pathway. J Cell Biol 196:7–18. doi:10.1083/jcb.201108111
55. Wu JW, Herman M, Liu L, Simoes S, Acker CM, Figueroa H, Steinberg JI, Margittai M, Kayed R, Zurzolo C et al (2013) Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J Biol Chem 288:1856–1870. doi:10.1074/jbc.M112.394528